Effects of Topical SLPI on Skin Wounds

NCT00005569 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Healthy
Wound Healing

Interventions

DRUG: SLPI (Secretory Leukocyte Protease Inhibitor)

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)